标题
Hepatitis C virus genotype 3: a genotype that is not ‘easy-to-treat’
作者
关键词
-
出版物
Expert Review of Gastroenterology & Hepatology
Volume 9, Issue 3, Pages 375-385
出版商
Informa UK Limited
发表日期
2014-09-15
DOI
10.1586/17474124.2015.960396
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Review article: HCV genotype 3 - the new treatment challenge
- (2014) J. Ampuero et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Metabolic Syndrome and Cardiometabolic Risk Factors
- (2014) Emilia Papakonstantinou et al. Current Vascular Pharmacology
- Variants of the inosine triphosphate pyrophosphatase gene are associated with reduced relapse risk following treatment for HCV genotype 2/3
- (2014) Karolina Rembeck et al. HEPATOLOGY
- HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV
- (2014) Fasiha Kanwal et al. HEPATOLOGY
- Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection
- (2014) Mark S. Sulkowski et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
- (2014) Mark S. Sulkowski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Individualization of chronic hepatitis C treatment according to the host characteristics
- (2014) Nikolaos K Gatselis WORLD JOURNAL OF GASTROENTEROLOGY
- Microbes and obesity—interrelationship between infection, adipose tissue and the immune system
- (2013) V. Hegde et al. CLINICAL MICROBIOLOGY AND INFECTION
- Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
- (2013) Donald B. Smith et al. HEPATOLOGY
- 1418 DACLATASVIR COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN FOR 12 OR 16 WEEKS IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION: COMMAND GT2/3 STUDY
- (2013) G.J. Dore et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2013) JOURNAL OF HEPATOLOGY
- Extended duration therapy with pegylated interferon and ribavirin for patients with genotype 3 hepatitis C and advanced fibrosis: Final results from the STEPS trial
- (2013) D. Shoeb et al. JOURNAL OF HEPATOLOGY
- Prevalence and Trends of Metabolic Syndrome in the Adult U.S. Population, 1999–2010
- (2013) Hiram Beltrán-Sánchez et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Treatment of hepatitis C virus genotype 3-infection
- (2013) Stanislas Pol et al. LIVER INTERNATIONAL
- New therapeutic strategies in HCV: second-generation protease inhibitors
- (2013) Virginia C. Clark et al. LIVER INTERNATIONAL
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pretransplant Serum Hepatitis C Virus RNA Levels Predict Response to Antiviral Treatment after Living Donor Liver Transplantation
- (2013) Yoshihide Ueda et al. PLoS One
- The Risk of Long-term Morbidity and Mortality in Patients With Chronic Hepatitis C
- (2013) Jeffrey McCombs et al. JAMA Internal Medicine
- Meta-analysis: the impact of IL28B polymorphisms on rapid and sustained virological response in HCV-2 and -3 patients
- (2012) J. Schreiber et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients
- (2012) P. Ramachandran et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants
- (2012) Vincenzo Summa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
- (2012) Khayriyyah Mohd Hanafiah et al. HEPATOLOGY
- Full-length genome sequences of five hepatitis C virus isolates representing subtypes 3g, 3h, 3i and 3k, and a unique genotype 3 variant
- (2012) L. Lu et al. JOURNAL OF GENERAL VIROLOGY
- HCV RNA decline in chronic HCV genotype 2 and 3 during standard of care treatment according to IL28B polymorphism
- (2012) J. Stenkvist et al. JOURNAL OF VIRAL HEPATITIS
- The pharmacogenetic background of hepatitis C treatment
- (2012) Christina Schlecker et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Influence of IL28B Polymorphisms on Response to a Lower-Than-Standard Dose peg-IFN-α 2a for Genotype 3 Chronic Hepatitis C in HIV-Coinfected Patients
- (2012) Luis F. López-Cortés et al. PLoS One
- Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3
- (2012) Åsa Alsiö et al. PLoS One
- IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C
- (2011) G. Fattovich et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Meta-analysis: insulin resistance and sustained virological response in hepatitis C
- (2011) M. Eslam et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: epidemiology of hepatitis C genotype 6 and its management
- (2011) D. T. Chao et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Ultra-Rapid Virological Response, Young Age, Low γ-GT/ALT-Ratio, and Absence of Steatosis Identify a Subgroup of HCV Genotype 3 Patients Who Achieve SVR with IFN-α2a Monotherapy
- (2011) Ahmad Amanzada et al. DIGESTIVE DISEASES AND SCIENCES
- Response to antiviral therapy in patients with genotype 3 chronic hepatitis C
- (2011) Dania Shoeb et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- IL28Bgenetic variation and treatment response in patients with hepatitis C virus genotype 3 infection
- (2011) Amir Moghaddam et al. HEPATOLOGY
- A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt
- (2011) William Sievert et al. LIVER INTERNATIONAL
- A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel
- (2011) Markus Cornberg et al. LIVER INTERNATIONAL
- HIV/hepatitis C coinfection natural history and disease progression
- (2011) Maria D. Hernandez et al. Current Opinion in HIV and AIDS
- Prediction of Response to Pegylated Interferon plus Ribavirin byIL28BGene Variation in Patients Coinfected with HIV and Hepatitis C Virus
- (2010) Juan A. Pineda et al. CLINICAL INFECTIOUS DISEASES
- ITPA Polymorphism Affects Ribavirin-Induced Anemia and Outcomes of Therapy—A Genome-Wide Study of Japanese HCV Virus Patients
- (2010) Hidenori Ochi et al. GASTROENTEROLOGY
- Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
- (2010) Andri Rauch et al. GASTROENTEROLOGY
- Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
- (2010) Fasiha Kanwal et al. GASTROENTEROLOGY
- Identifying hepatitis C virus genotype 2/3 patients who can receive a 16-week abbreviated course of peginterferon alfa-2a (40KD) plus ribavirin
- (2010) Moises Diago et al. HEPATOLOGY
- Induction and Evasion of Innate Antiviral Responses by Hepatitis C Virus
- (2010) Stanley M. Lemon JOURNAL OF BIOLOGICAL CHEMISTRY
- Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin
- (2010) Thomas-Matthias Scherzer et al. JOURNAL OF HEPATOLOGY
- Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients
- (2010) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- Rapid virological response is the most important predictor of sustained virological response across genotypes in patients with chronic hepatitis C virus infection
- (2010) Michael W. Fried et al. JOURNAL OF HEPATOLOGY
- Management of hepatitis C virus genotype 4: Recommendations of An International Expert Panel
- (2010) Mahmoud A. Khattab et al. JOURNAL OF HEPATOLOGY
- ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C
- (2010) Jacques Fellay et al. NATURE
- HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality
- (2009) Nikolai Mühlberger et al. BMC PUBLIC HEALTH
- Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin
- (2009) Michelle Martinot-Peignoux et al. HEPATOLOGY
- Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence
- (2009) Barbara Rehermann JOURNAL OF CLINICAL INVESTIGATION
- Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients
- (2009) Chia-Yen Dai et al. JOURNAL OF HEPATOLOGY
- The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report
- (2009) Nabil Antaki et al. LIVER INTERNATIONAL
- Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation
- (2009) Jan Peveling-Oberhag et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- The Metabolic Syndrome in South Asians: Epidemiology, Determinants, and Prevention
- (2009) Anoop Misra et al. Metabolic Syndrome and Related Disorders
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
- (2009) Vijayaprakash Suppiah et al. NATURE GENETICS
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
- Meta-analysis: the outcome of anti-viral therapy in HCV genotype 2 and genotype 3 infected patients with chronic hepatitis
- (2008) A. ANDRIULLI et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin
- (2008) Marina Berenguer JOURNAL OF HEPATOLOGY
- Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3
- (2007) Hossein Poustchi et al. JOURNAL OF HEPATOLOGY
- The changing epidemiology of hepatitis C virus infection in Europe
- (2007) Juan I. Esteban et al. JOURNAL OF HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now